Terminal signal: Anti-inflammatory effects of α-melanocyte- stimulating hormone related peptides beyond the pharmacophore

Advances in Experimental Medicine and Biology

Volumn 681, Issue , 2010, Pages 107-116

  Brzoska, Thomas ^a   Böhm, Markus ^b   Lügering, Andreas ^b   Loser, Karin ^b   Luger, Thomas A ^b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLLYSYLPROLYLVALYLTYROSINE AMIDE; ACETYLTYROSYLLYSYLPROLYLVALINE AMIDE; ADENYLATE CYCLASE; AFAMELANOTIDE; ALPHA INTERMEDIN; ALPHA INTERMEDIN DERIVATIVE; ANTIINFLAMMATORY AGENT; ARGINYLTRYPTOPHYLGLYCYLLYSYLPROLYLVALINE; ASPARAGINYLASPARTYLPROLINE INTERMEDIN; BETA INTERMEDIN; CELL ADHESION MOLECULE; CHEMOKINE RECEPTOR; CYTOKINE; GAMMA INTERMEDIN; GLYCYLLYSYLPROLYLVALINE; HISTIDYLPHENYLALANYLARGINYLTRYPTOPHANE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; LYSYL DEXTRO PROLYLTHREONINE; LYSYL DEXTRO PROLYLVALINE; LYSYLPROLYL DEXTRO VALINE; LYSYLPROLYLVALINE; MELANOCORTIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; NALOXONE; TRIDECACTIDE; TRYPTOPHYLGLYCYLLYSYLPROLYLVALINE; UNCLASSIFIED DRUG;

ALLERGIC VASCULITIS; AMINO ACID SEQUENCE; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTIPYRETIC ACTIVITY; ARTHRITIS; ARTICLE; BINDING AFFINITY; CELL ACTIVITY; CELL LEVEL; CELL MIGRATION; CELL PROLIFERATION; COLITIS; DIGESTIVE SYSTEM INFLAMMATION; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SAFETY; DRUG STABILITY; ENCEPHALITIS; ENZYME ACTIVATION; FEVER; FLUSHING; GASTROINTESTINAL SYMPTOM; HUMAN; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; IRRITANT DERMATITIS; LOW DRUG DOSE; NONHUMAN; OCULAR FIBROSIS; PHARMACOPHORE; PIGMENT DISORDER; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; RESPIRATORY TRACT INFLAMMATION; SEQUENCE ANALYSIS; SIDE EFFECT; SIGNAL TRANSDUCTION; SINGLE DRUG DOSE; SKIN ALLERGY; SKIN INFLAMMATION; SKIN PIGMENTATION; STRUCTURE ACTIVITY RELATION; T LYMPHOCYTE;

ALPHA-MSH; AMINO ACID SEQUENCE; ANIMALS; ANTI-INFLAMMATORY AGENTS; HUMANS; INFLAMMATION; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; RECEPTORS, MELANOCORTIN;

ANIMALIA;

EID: 79959562136     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-6354-3_8     Document Type: Article

References (66)

1. Lipton JM, Catania A. Anti-inflammatory actions of the neuroimmunomodulator alpha-MSH. Immunol Today 1997; 18:140-145.
2. Getting SJ. Targeting melanocortin receptors as potential novel therapeutics. Pharmacol Ther 2006; 111:1-15. (Pubitemid 43765537)
3. Luger TA, Scholzen TE, Brzoska T et al. New insights into the functions of alpha-MSH and related peptides in the immune system. Ann N Y Acad Sci 2003; 994:133-140. (Pubitemid 36793859)
4. Haskell-Luevano C, Sawyer TK, Hendrata S et al. Truncation studies of alpha-melanotropin peptides identify tripeptide analogues exhibiting prolonged agonist bioactivity. Peptides 1996; 17:995-1002. (Pubitemid 26355326)
5. Mountjoy KG, Robbins LS, Mortrud MT et al. The cloning of a family of genes that encode the melanocortin receptors. Science 1992; 257:1248-1251.
6. Cone RD, Lu D, Koppula S et al. The melanocortin receptors: Agonists, antagonists and the hormonal control of pigmentation. Recent Prog Horm Res 1996; 51:287-318.
7. Schiöth HB, Muceniece R, Larsson M et al. Binding of cyclic and linear MSH core peptides to the melanocortin receptor subtypes. J Pharmacol 1997; 319:369-373. (Pubitemid 27056061)
8. Elliott RJ, Szabo M, Wagner MJ et al. Alpha-Melanocyte-stimulating hormone, MSH 11-13 KPV and adrenocorticotropic hormone signalling in human keratinocyte cells. J Invest Dermatol 2004; 122:1010-1019. (Pubitemid 38581004)
9. Englaro W, Rezzonico R, Durand-Clement M et al. Mitogen-activated protein kinase pathway and AP-1 are activated during cAMP-induced melanogenesis in B-16 melanoma cells. J Biol Chem 1995; 270:24315-24320.
10. Böhm M, Luger TA, Tobin DJ et al. Melanocortin receptor ligands: New horizons for skin biology and clinical dermatology. J Invest Dermatol 2006; 126:1966-1975.
11. Colombo G, Buffa R, Bardella MT et al. Anti-inflammatory effects of alpha-melanocyte-stimulating hormone in celiac intestinal mucosa. Neuroimmunomodulation 2002; 10:208-216. (Pubitemid 36205297)
12. Bhardwaj R, Becher E, Mahnke K et al. Evidence for the differential expression of the functional alpha-melanocyte-stimulating hormone receptor MC-1 on human monocytes. J Immunol 1997; 158:3378-3384. (Pubitemid 127484057)
13. Cooper A, Robinson SJ, Pickard C et al. Alpha-melanocyte-stimulating hormone suppresses antigen-induced lymphocyte proliferation in humans independently of melanocortin 1 receptor gene status. J Immunol 2005; 175:4806-4813. (Pubitemid 41362024)
14. Andersen GN, Hagglund M, Nagaeva O et al. Quantitative measurement of the levels of melanocortin receptor subtype 1, 2, 3 and 5 and pro-opiomelanocortin peptide gene expression in subsets of human peripheral blood leucocytes. Scand J Immunol 2005; 61:279-284. (Pubitemid 40462779)
15. Catania A, Rajora N, Capsoni F et al. The neuropeptide alpha-MSH has specific receptors on neutrophils and reduces chemotaxis in vitro. Peptides 1996; 17:675-679. (Pubitemid 26238403)
16. Schiöth HB, Mutulis F, Muceniece R et al. Selective properties of C- and N-terminals and core residues of the melanocyte-stimulating hormone on binding to the human melanocortin receptor subtypes. Eur J Pharmacol 1998; 349:359-366. (Pubitemid 28277108)
17. Tatro JB, Entwistle ML. Heterogeneity of brain melanocortin receptors suggested by differential ligand binding in situ. Brain Res 1994; 635:148-158. (Pubitemid 24031399)
18. Lyson K, Ceriani G, Takashima A et al. Binding of anti-inflammatory alpha-melanocyte-stimulating-hormone peptides and proinflammatory cytokines to receptors on melanoma cells. Neuroimmunomodulation 1994; 1:121-126.
19. Mandrika I, Muceniece R, Wikberg JE. Effects of melanocortin peptides on lipopolysaccharide/ interferon-gamma-induced NF-kappaB DNA binding and nitric oxide production in macrophage-like RAW 264.7 cells: Evidence for dual mechanisms of action. Biochem Pharmacol 2001; 161:613-621. (Pubitemid 32178496)
20. Delgado R, Carlin A, Airaghi L et al. Melanocortin peptides inhibit production of proinflammatory cytokines and nitric oxide by activated microglia. J Leukoc Biol 1998; 63:740-745. (Pubitemid 28274836)
21. Getting SJ, Schiöth HB, Perretti M. Dissection of the anti-inflammatory effect of the core and C-terminal (KPV) alpha-melanocyte- stimulating hormone peptides. J Pharmacol Exp Ther 2003; 306:631-637. (Pubitemid 36886162)
22. Schiöth HB, Muceniece R, Mutule I et al. New melanocortin 1 receptor binding motif based on the C-terminal sequence of alpha-melanocyte-stimulating hormone. Basic Clin Pharmacol Toxicol 2006; 99:287-293. (Pubitemid 44578904)
23. Poole S, Bristow AF, Lorenzetti BB et al. Peripheral analgesic activities of peptides related to alpha-melanocyte stimulating hormone and interleukin-1 beta 193-195. Br J Pharmacol 1992; 106:489-492.
24. Mugridge KG, Perretti M, Ghiara P et al. Alpha-melanocyte-stimulating hormone reduces interleukin-1 beta effects on rat stomach preparations possibly through interference with a type I receptor. Eur J Pharmacol 1991; 197:151-155.
25. Ichiyama T, Sakai T, Catania A et al. Inhibition of peripheral NF-kappaB activation by central action of alpha-melanocyte-stimulating hormone. J Neuroimmunol 1999; 99:211-217. (Pubitemid 29518233)
26. Dalmasso G, Charrier-Hisamuddin L, Thu Nguyen HT et al. PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology 2008; 134:166-178. (Pubitemid 350309324)
27. Wong KY, Rajora N, Boccoli G et al. A potential mechanism of local anti-inflammatory action of alpha-melanocyte-stimulating hormone within the brain: Modulation of tumor necrosis factor-alpha production by human astrocytic cells. Neuroimmunomodulation 1997; 4:37-41. (Pubitemid 27397857)
28. Galimberti D, Baron P, Meda L et al. Alpha-MSH peptides inhibit production of nitric oxide and tumor necrosis factor-alpha by microglial cells activated with beta-amyloid and interferon gamma. Biochem Biophys Res Commun 1999; 263:251-256. (Pubitemid 29443671)
29. Muceniece R, Krigere L, Suli-Vargha H et al. Effects of alpha-melanotropin C-terminal tripeptide analogues on macrophage NO production. Peptides 2003; 24:701-707. (Pubitemid 36930000)
30. Moustafa M, Szabo M, Ghanem GE et al. Inhibition of tumor necrosis factor-alpha stimulated NFkappaB/ p65 in human keratinocytes by alpha-melanocyte stimulating hormone and adrenocorticotropic hormone peptides. J Invest Dermatol 2002; 119:1244-1253. (Pubitemid 36005605)
31. Barcellini W, Colombo G, La Maestra L et al. Alpha-melanocyte-stimulating hormone peptides inhibit HIV-1 expression in chronically infected promonocytic U1 cells and in acutely infected monocytes. J Leukoc Biol 2000; 68:693-699.
32. Haddad JJ, Lauterbach R, Saade NE et al. Alpha-melanocyte-related tripeptide, Lys-d-Pro-Val, ameliorates endotoxin-induced nuclear factor kappaB translocation and activation: Evidence for involvement of an interleukin-1beta193-195 receptor antagonism in the alveolar epithelium. Biochem J 2001; 355:29-38. (Pubitemid 32318324)
33. Hiltz ME, Catania A, Lipton JM. Anti-inflammatory activity of alpha-MSH(11-13) analogs: Influences of alteration in stereochemistry. Peptides 1991; 12:767-771.
34. Bhardwaj RS, Schwarz A, Becher E et al. Pro-opiomelanocortin-derived peptides induce IL-10 production in human monocytes. J Immunol 1996; 156:2517-2521.
35. Böhm M, Wolff I, Scholzen TE et al. Alpha-Melanocyte-stimulating hormone protects from ultraviolet radiation-induced apoptosis and DNA damage. J Biol Chem 2005; 280:5795-5802. (Pubitemid 40280060)
36. Richards DB, Lipton JM. Effect of alpha-MSH 11-13 (lysine-proline-valine) on fever in the rabbit. Peptides 1984; 5:815-817. (Pubitemid 14058564)
37. Deeter LB, Martin LW, Lipton JM. Antipyretic properties of centrally administered alpha-MSH fragments in the rabbit. Peptides 1989b; 9:1285-1288. (Pubitemid 19265219)
38. Ichiyama T, Sakai T, Catania A et al. Systemically administered alpha-melanocyte-stimulating peptides inhibit NF-kappaB activation in experimental brain inflammation. Brain Res 1999; 836:31-37. (Pubitemid 29354468)
39. Hiltz ME, Lipton JM. Alpha-MSH peptides inhibit acute inflammation and contact sensitivity. Peptides 1990; 11:979-982. (Pubitemid 20337195)
40. Hiltz ME, Catania A, Lipton JM. Alpha-MSH peptides inhibit acute inflammation induced in mice by rIL-1 beta, rIL-6, rTNF-alpha and endogenous pyrogen but not that caused by LTB4, PAF and rIL-8. Cytokine 1992; 4:320-328.
41. Macaluso A, McCoy D, Ceriani G et al. Antiinflammatory influences of alpha-MSH molecules: Central neurogenic and peripheral actions. J Neurosci 1994; 14:2377-2382.
42. Ceriani G, Macaluso A, Catania A et al. Central neurogenic antiinflammatory action of alpha-MSH: Modulation of peripheral inflammation induced by cytokines and other mediators of inflammation. Neuroendocrinology 1994; 59:138-143. (Pubitemid 24032709)
43. Hiltz ME, Lipton JM. Antiinflammatory activity of a COOH-terminal fragment of the neuropeptide alpha-MSH. FASEB J 1989; 3:2282-2284. (Pubitemid 19229615)
44. Ferreira SH, Lorenzetti BB, Bristow AF et al. Interleukin-1βas a potent hyperalgesic agent antagonized by a tripeptide analogue. Nature 1988; 334:698-700.
45. Oluyomi AO, Poole S, Smith TW et al. Antinociceptive activity of peptides related to interleukin-1 beta-(193-195), Lys-Pro-Thr. Eur J Pharmacol 1994; 258:131-138. (Pubitemid 24174995)
46. Maaser C, Kannengiesser K, Lügering A et al. Successful treatment of murine colitis with the tripeptide KPV. Gastroenterology 2005; 128:A-2001.
47. Maser C, Bettenworth D, Lügering A et al. Therapeutischer Einsatz des Tripeptids K(D)PT im murinen DSS-Modell. Z Gastroenterol 2006; 44:724.
48. Kannengiesser K, Maaser C, Heidemann J et al. Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease. Inflamm Bowel Dis 2008; 14:324-331. (Pubitemid 351441320)
49. Harms J, Lautenschlager S, Minder CE et al. An alpha-melanocyte- stimulating hormone analogue in erythropoietic protoporphyria. N Engl J Med 2009; 360(3):306-307.
50. Evans-Brown M, Dawson RT, Chandler M et al. Use of melanotan I and II in the general population. BMJ 2009; 338:424-425.
51. Lipton JM. Modulation of host defense by the neuropeptide alpha-MSH. Yale J Biol Med 1990; 63:173-182. (Pubitemid 20342086)
52. Potaman VN, Alfeeva LY, Kamensky AA et al. Degradation of ACTH/MSH(4-10) and its synthetic analog semax by rat serum enzymes: An inhibitor study. Peptides 1993; 14:491-495.
53. Castrucci AM, Hadley ME, Sawyer TK et al. Enzymological studies of melanotropins. Comp Biochem Physiol 1984; 78:519-524.
54. Marks N, Stern F, Kastin AJ. Biodegradation of alpha-MSH and derived peptides by rat brain extracts and by rat and human serum. Brain Res Bull 1976; 1:591-593. (Pubitemid 8093250)
55. Trochard MC, Vaudry H, Leboulenger F et al. The degradation of radioiodinated alpha MSH in vitro: Effect of some inhibitors of proteolytic enzymes. C R Seances Soc Biol Fil 1976; 170:1103-1109. (Pubitemid 8039082)
56. Deschodt-Lanckman M, Vanneste Y, Loir B et al. Degradation of alpha-melanocyte stimulating hormone (alpha-MSH) by CALLA/endopeptidase 24.11 expressed by human melanoma cells in culture. Int J Cancer 1990; 46:1124-1130.
57. Aberdam E, Auberger P, Ortonne JP et al. Neprilysin, a novel target for ultraviolet B regulation of melanogenesis via melanocortins. J Invest Dermatol 2000; 115:381-387.
58. Hruby VJ, Wilkes BC, Hadley ME et al. Alpha-Melanotropin: The minimal active sequence in the frog skin bioassay. J Med Chem 1987; 30:2126-2130. (Pubitemid 18046075)
59. Meyer KC, Brzoska T, Abels C et al. The alpha-melanocyte stimulating hormone-related tripeptide K(D)PT stimulates human hair follicle pigmentation in situ under proinflammatory conditions. Br J Dermatol 2008; 160:433-437.
60. Kang L, McIntyre KW, Gillooly KM et al. A selective small molecule agonist of the melanocortin-1 receptor inhibits lipopolysaccharide-induced cytokine accumulation and leukocyte infiltration in mice. J Leukoc Biol 2006; 80:897-904. (Pubitemid 44835908)
61. Ugwu SO, Blanchard J, Dorr RT et al. Skin pigmentation and pharmacokinetics of melanotan-I in humans. Bioph Drug 1997; 18:259-269. (Pubitemid 27191805)
62. 7]-alpha-MSH in humans. Photochem Photobiol 2000; 72:526-532.
63. Dorr RT, Ertl G, Levine N et al. Effects of a superpotent melanotropic peptide in combination with solar UV radiation on tanning of the skin in human volunteers. Arch Dermatol 2004; 140:827-835. (Pubitemid 38917851)
64. Hadley ME, Dorr RT. Melanocortin peptide therapeutics: Historical milestones, clinical studies and commercialization. Peptides 2006; 27:921-930.
65. Baugh JA, Bucala R. Mechanisms for modulating TNF alpha in immune and inflammatory disease. Curr Opin Drug Discov Devel 2001; 4:635-650. (Pubitemid 32904860)
66. Cutuli M, Cristiani S, Lipton JM et al. Antimicrobial effects of alpha-MSH peptides. J Leukoc Biol 2000; 67:233-239.